Static Chart Aligos Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-16 EDT			5-day change	1st Jan Change
0.655 ^USD	-3.55%		-15.65%	-1.36%

04-03	Aligos Therapeutics, Inc. Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects	CI
03-27	Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies	CI

Duration

Period